Efficacy and safety of esaxerenone (CS-3150) for the treatment of type 2 diabetes with microalbuminuria A randomized, double-blind, placebo-controlled, phase ii trial

Sadayoshi Ito, Kenichi Shikata, Masaomi Nangaku, Yasuyuki Okuda, Tomoko Sawanobori

Research output: Contribution to journalArticlepeer-review

26 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Efficacy and safety of esaxerenone (CS-3150) for the treatment of type 2 diabetes with microalbuminuria A randomized, double-blind, placebo-controlled, phase ii trial'. Together they form a unique fingerprint.

Medicine & Life Sciences